Franklin Resources’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.1M Buy
582,182
+91,089
+19% +$689K ﹤0.01% 1592
2026
Q1
$3.77M Buy
491,093
+404,020
+464% +$2.77M ﹤0.01% 1646
2025
Q4
$172K Sell
87,073
-68
-0.1% -$154 ﹤0.01% 2824
2025
Q3
$214K Hold
87,141
﹤0.01% 2807
2025
Q2
$230K Buy
+87,141
New +$234K ﹤0.01% 2691
2025
Q1
Sell
-88,686
Closed -$227K 3020
2024
Q4
$227K Sell
88,686
-105,756
-54% -$441K ﹤0.01% 2614
2024
Q3
$723K Sell
194,442
-4,739
-2% -$21.9K ﹤0.01% 2121
2024
Q2
$1.26M Sell
199,181
-192,571
-49% -$1.27M ﹤0.01% 1842
2024
Q1
$2.1M Buy
+391,752
New +$1.77M ﹤0.01% 1700
2021
Q4
Sell
-19,500
Closed -$190K 2509
2021
Q3
$190K Buy
+19,500
New +$215K ﹤0.01% 2241
2017
Q1
Sell
-110,389
Closed -$631K 1507
2016
Q4
$631K Sell
110,389
-931,438
-89% -$6.21M ﹤0.01% 1356
2016
Q3
$8.11M Hold
1,041,827
﹤0.01% 1017
2016
Q2
$6.48M Sell
1,041,827
-718,800
-41% -$5.58M ﹤0.01% 1055
2016
Q1
$14.5M Sell
1,760,627
-4,920
-0.3% -$46.4K 0.01% 883
2015
Q4
$28.8M Sell
1,765,547
-157,654
-8% -$2.34M 0.01% 726
2015
Q3
$22M Buy
+1,923,201
New +$42M 0.01% 818

Other funds holding IBRX

Franklin Resources's IBRX Position: Q2 2026 in Review

Franklin Resources increased its ImmunityBio (IBRX) stake by 19% in Q2 2026, buying an estimated $689K and bringing the position to 582,182 shares worth $5.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Franklin Resources first reported a position in IBRX in Q3 2015 and has held it in 16 quarters since. The position peaked at $28.8M in Q4 2015. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Franklin Resources held 582,182 shares of ImmunityBio worth $5.1M as of Q2 2026.
  • Franklin Resources bought 91,089 ImmunityBio shares in Q2 2026, an estimated $689K.
  • ImmunityBio made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1592 holding.
  • Franklin Resources first reported a position in ImmunityBio in Q3 2015 and has held it in 16 quarters since.
  • Franklin Resources's ImmunityBio position peaked at $28.8M in Q4 2015.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.